©bongkarn thanyakij via Canva.com
FDA Review and Approval Process for Combination Products - LIVE WEBINAR
This Webinar is over| Date | Aug 31, 2016 |
| Time | 12:00 PM EDT |
| Cost | $199.00 |
|
Online
|
The United States Food and Drug Administration (FDA) reviews, clears or approves regulatory applications for drugs, biologics, medical devices including in vitro diagnostic devices (IVDs) and combination products.
It is imperative that firms identify and map evolving regulatory requirements so that regulatory submissions for in particular, combination products, can be better prepared for and managed with awareness in advance.
This seminar is intended to discuss regulatory requirements relevant and applicable to combination products. It is further intended to discuss CGMP requirements for combination products.
The best practices for enforcing a practical, actionable and sustainable regulatory approaches will be discussed, helping to save a significant amount of resources (time, efforts and financial).
In this seminar, the speaker will discuss what firms should consider and address when developing combination products and navigating through FDA’s regulatory pathways.
It is imperative that firms identify and map evolving regulatory requirements so that regulatory submissions for in particular, combination products, can be better prepared for and managed with awareness in advance.
This seminar is intended to discuss regulatory requirements relevant and applicable to combination products. It is further intended to discuss CGMP requirements for combination products.
The best practices for enforcing a practical, actionable and sustainable regulatory approaches will be discussed, helping to save a significant amount of resources (time, efforts and financial).
In this seminar, the speaker will discuss what firms should consider and address when developing combination products and navigating through FDA’s regulatory pathways.
Create your own event
Turn your passion into a business.
Turn your passion into a business.